Nanhua Bio Medicine Stock Return On Asset

000504 Stock   8.85  0.03  0.34%   
Nanhua Bio Medicine fundamentals help investors to digest information that contributes to Nanhua Bio's financial success or failures. It also enables traders to predict the movement of Nanhua Stock. The fundamental analysis module provides a way to measure Nanhua Bio's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Nanhua Bio stock.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Nanhua Bio Medicine Company Return On Asset Analysis

Nanhua Bio's Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.

Return On Asset

 = 

Net Income

Total Assets

More About Return On Asset | All Equity Analysis

Current Nanhua Bio Return On Asset

    
  -0.0455  
Most of Nanhua Bio's fundamental indicators, such as Return On Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Nanhua Bio Medicine is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.
Competition

Nanhua Total Assets

Total Assets

359.5 Million

At present, Nanhua Bio's Total Assets are projected to increase significantly based on the last few years of reporting.
Based on the latest financial disclosure, Nanhua Bio Medicine has a Return On Asset of -0.0455. This is 101.1% lower than that of the Media sector and significantly lower than that of the Communication Services industry. The return on asset for all China stocks is 67.5% lower than that of the firm.

Nanhua Return On Asset Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Nanhua Bio's direct or indirect competition against its Return On Asset to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Nanhua Bio could also be used in its relative valuation, which is a method of valuing Nanhua Bio by comparing valuation metrics of similar companies.
Nanhua Bio is currently under evaluation in return on asset category among its peers.

Nanhua Fundamentals

About Nanhua Bio Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Nanhua Bio Medicine's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Nanhua Bio using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Nanhua Bio Medicine based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Other Information on Investing in Nanhua Stock

Nanhua Bio financial ratios help investors to determine whether Nanhua Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Nanhua with respect to the benefits of owning Nanhua Bio security.